COGT (Cogent Biosciences) Stock Based Compensation: $52.98 Mil (TTM As of Mar. 2026)


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $38.72
! 4 Warning Signs
View Full Analysis

What is Cogent Biosciences Stock Based Compensation?

Cogent Biosciences COGT +0.55% 25 Stock Based Compensation is $52.98 Mil as of Mar. 2026. GuruFocus rates COGT with a GF Score™ of 25/100. The stock has 4 warning signs investors should review.

Cogent Biosciences's Stock Based Compensation for the three months ended in Mar. 2026 was $16.91 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $52.98 Mil.

Cogent Biosciences Stock Based Compensation Related Terms

Cogent Biosciences Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Cogent Biosciences's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogent Biosciences Stock Based Compensation Chart

Cogent Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.69 18.37 30.62 39.74 46.08

Cogent Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.01 9.72 10.60 15.75 16.91
COGT
25GF Score
Cogent Biosciences Inc COGT
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $52.98 Mil.

What does a Stock Based Compensation of $52.98 Mil mean?
Cogent Biosciences (COGT) has a Stock Based Compensation of $52.98 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Cogent Biosciences and its competitors.
Is Cogent Biosciences' Stock Based Compensation too high?
Cogent Biosciences' current Stock Based Compensation is $52.98 Mil. Overall, Cogent Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' Stock Based Compensation compare to SRRK and CGON?
Cogent Biosciences' Stock Based Compensation of $52.98 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Cogent Biosciences and its competitors. Cogent Biosciences's current Stock Based Compensation is $52.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current Stock Based Compensation of $52.98 Mil. The current Stock Based Compensation is $52.98 Mil. Cogent Biosciences' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current Stock Based Compensation is $52.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$38.72
Price